RxNorm Semantic Concepts Index - 195
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "195".
| Concept ID (RxCUI) | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| Concept ID (RxCUI): 195 | Choline esterase I | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 195 | Choline esterase I | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 195 | Choline esterase I | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 195 | Choline esterase I | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 195 | Choline esterase I | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 195 | Choline esterase I | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 195 | Choline esterase I | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 195 | Choline esterase I | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 195 | Choline esterase I | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 195 | Choline esterase I | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 195 | Choline esterase I | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 195084 | Sustiva | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 195085 | efavirenz | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 195085 | efavirenz | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 195085 | efavirenz | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 195085 | efavirenz | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 195085 | efavirenz | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 195088 | lopinavir | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 195088 | lopinavir | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 195088 | lopinavir | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 195088 | lopinavir | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 195088 | lopinavir | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1951 | Cambendazole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1951 | Cambendazole | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1951 | Cambendazole | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1951232 | Anti-A2 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1951232 | Anti-A2 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1951232 | Anti-A2 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1951749 | Anti-actin IgG | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1951749 | Anti-actin IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1951749 | Anti-actin IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1951749 | Anti-actin IgG | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1952 | Camphor | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1952 | Camphor | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1952 | Camphor | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1952 | Camphor | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1952 | Camphor | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1953 | Camptothecin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1953 | Camptothecin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1954200 | Product containing thiosulfuric acid (medicinal product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1954200 | Product containing thiosulfuric acid (medicinal product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1954200 | Product containing thiosulfuric acid (medicinal product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1954200 | Product containing thiosulfuric acid (medicinal product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1954720 | Antibody to chromatin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1954720 | Antibody to chromatin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1954720 | Antibody to chromatin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1954720 | Antibody to chromatin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1954720 | Antibody to chromatin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 19551 | pemirolast | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 19551 | pemirolast | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 19551 | pemirolast | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 19551 | pemirolast | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 19551 | pemirolast | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 19552 | cefprozil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 19552 | cefprozil | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 19552 | cefprozil | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 19552 | cefprozil | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 19552 | cefprozil | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 195526 | Lymphocyte antigen FMC7 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 195526 | Lymphocyte antigen FMC7 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 195589 | Putrescine methyltransferase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 195589 | Putrescine methyltransferase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1956213 | Iron-containing product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1956213 | Iron-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 19574 | Boldine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 19574 | Boldine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1957663 | Adult elemental anti-inflammatory GI intolerance critical care specialty formula | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1957663 | Adult elemental anti-inflammatory GI intolerance critical care specialty formula | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1957828 | Soy-based infant formula | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1957828 | Soy-based infant formula | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1958200 | 223-Ra | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1958200 | 223-Ra | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1958200 | 223-Ra | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1958200 | 223-Ra | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1958200 | 223-Ra | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1958225 | Discovered on gastrointestinal stromal tumors protein 1 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1958225 | Discovered on gastrointestinal stromal tumors protein 1 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1958225 | Discovered on gastrointestinal stromal tumors protein 1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1958225 | Discovered on gastrointestinal stromal tumors protein 1 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1958225 | Discovered on gastrointestinal stromal tumors protein 1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 19596 | bone meal | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 195983 | calcium bromide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |